Insider Trading & Ownership - Ocumension Therapeutics

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ocumension Therapeutics
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-11
Sale
2024-01-16
6:55 pm
EyePoint Pharmaceuticals Inc. EYEP Ocumension Therapeutics
Director
1,910,500 $19.45 $37,159,225 100,221
(Direct)
View
2023-12-05
Sale
2023-12-07
9:21 pm
EyePoint Pharmaceuticals Inc. EYEP Ocumension Therapeutics
Director
1,000,000 $19.51 $19,510,637 2,010,721
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2021-04-30
1:18 pm
N/A
N/A
ALIMERA SCIENCES INC ALIM Ocumension Therapeutics
10% Owner
0 $0 1,144,945
(Direct)
View

Ownership
2021-01-14
08:07 am
N/A
N/A
EyePoint Pharmaceuticals Inc. EYPT OcuMension Therapeutics
10% Owner
0 $0 3,010,722
(Direct)
View